{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:22:16Z","timestamp":1779927736922,"version":"3.53.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.clinthera.2015.05.495","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T22:08:01Z","timestamp":1441750081000},"page":"1897-1923","source":"Crossref","is-referenced-by-count":71,"title":["Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing"],"prefix":"10.1016","volume":"37","author":[{"given":"Jennifer G.","family":"Kendrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane R.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary H.H.","family":"Ensom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.05.495_bib1","year":"2013","journal-title":"Childhood overweight and obesity"},{"key":"10.1016\/j.clinthera.2015.05.495_bib2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3945\/ajcn.2010.29786","article-title":"Global prevalence and trends of overweight and obesity among preschool children","volume":"92","author":"de Onis","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinthera.2015.05.495_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2012.40","article-title":"Prevalence of obesity and trends in body mass index among US children and adolescents, 1990-2010","volume":"307","author":"Ogden","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2015.05.495_bib4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1017\/S1368980008002280","article-title":"Relationship between BMI and blood pressure in girls and boys","volume":"11","author":"Gundogdu","year":"2008","journal-title":"Public Health Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2015.05.495_bib5","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.2337\/dc08-s273","article-title":"Metabolic complications of childhood obesity","volume":"31","author":"Weiss","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2015.05.495_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/MED.0b013e3282f43d19","article-title":"Metabolic complications of obesity in childhood and adolescence: more than just diabetes","volume":"15","author":"Nathan","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.clinthera.2015.05.495_bib7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2214\/AJR.06.0651","article-title":"Diseases associated with childhood obesity","volume":"188","author":"Choudhary","year":"2007","journal-title":"AJR"},{"key":"10.1016\/j.clinthera.2015.05.495_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0031-3955(03)00114-7","article-title":"Childhood obesity","volume":"49","author":"Strauss","year":"2002","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clinthera.2015.05.495_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pcl.2013.09.013","article-title":"Identification of obesity and cardiovascular risk factors in childhood and adolescence","volume":"61","author":"Balakrisnan","year":"2014","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.clinthera.2015.05.495_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2605.2005.00602.x","article-title":"Influence of obesity on timing of puberty","volume":"29","author":"Biro","year":"2006","journal-title":"Int J Androl"},{"key":"10.1016\/j.clinthera.2015.05.495_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.beem.2005.04.005","article-title":"Effects of obesity on growth and puberty","volume":"19","author":"Dunger","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2015.05.495_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/QCO.0b013e328359a4c1","article-title":"Dosing of antibiotics in obesity","volume":"25","author":"Janson","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clinthera.2015.05.495_bib13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3928\/01477447-20061101-08","article-title":"Pharmacokinetic alterations in obesity","volume":"29","author":"Lee","year":"2006","journal-title":"Orthopedics"},{"key":"10.1016\/j.clinthera.2015.05.495_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jclinane.2004.01.009","article-title":"Anesthesia in the obese patient: pharmacokinetic considerations","volume":"17","author":"Casati","year":"2005","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.clinthera.2015.05.495_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00134-003-2059-6","article-title":"Dosing of medications in morbidly obese patients in the intensive care unit setting","volume":"30","author":"Erstad","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clinthera.2015.05.495_bib16","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1177\/1060028013509789","article-title":"Dosing considerations for obese patients receiving cancer chemotherapeutic agents","volume":"47","author":"Hall","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2015.05.495_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cjca.2014.10.025","article-title":"The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control","volume":"31","author":"Sankaralingam","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2015.05.495_bib19","first-page":"94","article-title":"Pharmacokinetics and drug dosing in obese children","volume":"15","author":"Kendrick","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2015.05.495_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/adc.2009.163055","article-title":"Dosing dilemmas in obese children","volume":"95","author":"Mulla","year":"2010","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2015.05.495_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1467-789X.2004.00133.x","article-title":"International Obesity Task Force. Obesity in children and young people","volume":"5","author":"Lobstein","year":"2004","journal-title":"Obes Rev"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2015.05.495_bib22","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1542\/peds.2007-2329D","article-title":"Assessment of child and adolescent overweight and obesity","volume":"120","author":"Krebs","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2015.05.495_bib23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1177\/15648265040251S104","article-title":"Measurement and standardization protocols for anthropometric used in the construction of a new international growth reference","volume":"25","author":"de Onis","year":"2004","journal-title":"Food Nutrition Bull"},{"key":"10.1016\/j.clinthera.2015.05.495_bib24","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1542\/peds.2008-3586E","article-title":"The validity of BMI as an indicator of body fatness and risk among children","volume":"124","author":"Freedman","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2015.05.495_bib25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/sj.ijo.0803402","article-title":"Body composition in normal weight, overweight, and obese children: matched case-control analyses of total and regional tissue masses, and body composition trends in relation to relative weight","volume":"30","author":"Wells","year":"2006","journal-title":"Int J Obes"},{"key":"10.1016\/j.clinthera.2015.05.495_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1152\/jappl.1995.79.1.94","article-title":"Relative expansion of extracellular water in obese vs. normal children","volume":"79","author":"Battistini","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib27","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003088-200645110-00003","article-title":"Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations","volume":"45","author":"Bartelink","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2015.05.495_bib28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2015.05.495_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2125.2004.02157.x","article-title":"What is the best size descriptor to use for pharmacokinetic studies in the obese?","volume":"58","author":"Green","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200544100-00004","article-title":"Quantification of lean bodyweight","volume":"44","author":"Janmahasatian","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2015.05.495_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0115426507022002240","article-title":"Ideal body weight in children","volume":"22","author":"Phillips","year":"2007","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clinthera.2015.05.495_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1023\/A:1015968407226","article-title":"Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological and pharmacokinetic concepts","volume":"6","author":"Koshida","year":"1989","journal-title":"Pharm Res"},{"key":"10.1016\/j.clinthera.2015.05.495_bib33","article-title":"AHFS Drug Information","year":"2014"},{"key":"10.1016\/j.clinthera.2015.05.495_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/pan.12396","article-title":"A retrospective description of anesthetic medication dosing in overweight and obese children","volume":"24","author":"Burke","year":"2014","journal-title":"Pediatric Anesthesia"},{"key":"10.1016\/j.clinthera.2015.05.495_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5055\/jom.2013.0156","article-title":"Codeine-associated pediatric deaths despite using recommended dosing guidelines: three case reports","volume":"9","author":"Friedrichsdorf","year":"2013","journal-title":"J Opioid Management"},{"key":"10.1016\/j.clinthera.2015.05.495_bib36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2146\/ajhp140280","article-title":"Development of recommendations for dosing of commonly prescribed medications in critically ill obese children","volume":"72","author":"Ross","year":"2015","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.clinthera.2015.05.495_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1460-9592.2011.03559.x","article-title":"Anesthetizing the obese child","volume":"21","author":"Mortensen","year":"2011","journal-title":"Pediatr Anesthesia"},{"key":"10.1016\/j.clinthera.2015.05.495_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/ACO.0b013e3282f82bbb","article-title":"Child obesity and anaesthetic morbidity","author":"Veyckemans","year":"2008","journal-title":"Curr Opin Anesthesiol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.aia.0000196250.61280.65","article-title":"Anesthesia for adolescent bariatric surgery","volume":"44","author":"Samuels","year":"2006","journal-title":"Int Anesthesiol Clin"},{"key":"10.1016\/j.clinthera.2015.05.495_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1460-9592.2002.00781.x","article-title":"Childhood obesity: a challenge for the anaesthetist?","volume":"12","author":"Smith","year":"2002","journal-title":"Paediat Anaesth"},{"key":"10.1016\/j.clinthera.2015.05.495_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1213\/ANE.0b013e318256858f","article-title":"The effect of obesity on the ED95 of propofol for loss of consciousness in children and adolescents","volume":"115","author":"Olutoye","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clinthera.2015.05.495_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF03261930","article-title":"Propofol clearance in morbidly obese children and adolescents","volume":"51","author":"Diepstraten","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2015.05.495_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/PEC.0b013e3181cbeb00","article-title":"Antibiotic dosing for acute otitis media in children. A weighty issue","volume":"26","author":"Christian-Kopp","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.clinthera.2015.05.495_bib44","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"American Academy of Pediatrics. Clinical Practice Guideline: The diagnosis and management of acute otitis media","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2015.05.495_bib45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1248\/bpb1978.10.436","article-title":"Comparative distribution kinetics of cefazolin and tobramycin in children","volume":"10","author":"Koshida","year":"1987","journal-title":"J Pharmacobio-Dyn"},{"key":"10.1016\/j.clinthera.2015.05.495_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/INF.0b013e3181ff023e","article-title":"Altered gentamicin serum concentrations in obese pediatric patients","volume":"30","author":"Choi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2015.05.495_bib47","series-title":"Pediatric & Neonatal Dosage Handbook","first-page":"1143","author":"Taketomo","year":"2012"},{"key":"10.1016\/j.clinthera.2015.05.495_bib48","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0009922810393500","article-title":"Vancomycin dosing in obese pediatric patients","volume":"50","author":"Moffett","year":"2011","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.clinthera.2015.05.495_bib49","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.2146\/ajhp110107","article-title":"Vancomycin dosage in overweight and obese children","volume":"68","author":"Miller","year":"2011","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.clinthera.2015.05.495_bib50","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/phar.1321","article-title":"Vancomycin trough concentration in overweight or obese pediatric patients","volume":"33","author":"Heble","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2015.05.495_bib51","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1345\/aph.1Q090","article-title":"Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory","volume":"45","author":"Moffett","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2015.05.495_bib52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpeds.2012.12.095","article-title":"Evaluation of weight-based dosing of unfractionated heparin in obese children","volume":"163","author":"Taylor","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2015.05.495_bib53","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1542\/peds.2010-0746","article-title":"Increased enoxaparin dosing is required for obese children","volume":"127","author":"Lewis","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2015.05.495_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpeds.2012.07.047","article-title":"Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin","volume":"162","author":"Richard","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2015.05.495_bib55","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1097\/MPH.0000000000000087","article-title":"Response to warfarin therapy in obese pediatric patients dosed according to institutional guidelines","volume":"36","author":"Moffett","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib56","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1200\/JCO.2007.11.2938","article-title":"Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese","volume":"25","author":"Sparreboon","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ctrv.2008.07.005","article-title":"Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA)","volume":"35","author":"Hunter","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clinthera.2015.05.495_bib58","first-page":"1","article-title":"Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline","volume":"99","author":"Griggs","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib59","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/cncr.21584","article-title":"L-asparaginase as a marker of chemotherapy dose modification in children with acute lymphoblastic leukemia","volume":"104","author":"Baillargeon","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2015.05.495_bib60","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1002\/cncr.27640","article-title":"Effect of body mass index on the outcome of children with acute myeloid leukemia","volume":"118","author":"Inaba","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2015.05.495_bib61","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2006-05-024414","article-title":"Body mass index does not influence pharmacokinetics or outcome of treatment of children with acute lymphoblastic leukemia","volume":"108","author":"Hijiya","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2015.05.495_bib62","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/oby.2011.195","article-title":"Overweight as a prognostic factor in children with acute lymphoblastic leukemia","volume":"19","author":"Gelelete","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/j.clinthera.2015.05.495_bib63","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1200\/JCO.2006.07.7792","article-title":"Obesity and outcome in pediatric acute lymphoblastic leukemia","volume":"25","author":"Butturini","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.293.2.203","article-title":"Mortality in overweight and underweight children with acute myeloid leukemia","volume":"291","author":"Lange","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2015.05.495_bib65","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1702700","article-title":"Retrospective appraisal of busulfan dose adjustment in children","volume":"26","author":"Dupuis","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clinthera.2015.05.495_bib66","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bmt.1703926","article-title":"Retrospective appraisal of busulfan dose adjustment in children","volume":"31","author":"Dupuis","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clinthera.2015.05.495_bib67","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbmt.2011.01.013","article-title":"Busulfan dosing in children with BMIs \u2265 85% undergoing HSCT: a new optimal strategy","volume":"17","author":"Browning","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clinthera.2015.05.495_bib68","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199802193380803","article-title":"Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia","volume":"338","author":"Evans","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2015.05.495_bib69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.leu.2401673","article-title":"Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia","volume":"14","author":"Wall","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.clinthera.2015.05.495_bib70","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1019755608555","article-title":"Limited and optimal sampling strategies for etoposide and etoposide catechol in children with leukemia","volume":"29","author":"Relling","year":"2002","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.clinthera.2015.05.495_bib71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00280-014-2535-4","article-title":"Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children\u2019s Oncology Group","volume":"74","author":"Thompson","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/08880010701451343","article-title":"Pharmacokinetics of doxorubicin and etoposide in a morbidly obese pediatric patient","volume":"24","author":"Ritzmo","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00001813-200002000-00010","article-title":"A comparative pharmacokinetic study of doxorubicin and 4-epi-doxorubicin in children with acute lymphoblastic leukemia using a limited sampling procedure","volume":"11","author":"Eksborg","year":"2000","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.clinthera.2015.05.495_bib74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00280-008-0854-z","article-title":"Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study","volume":"64","author":"Thompson","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00001813-200004000-00002","article-title":"Plasma pharmacokinetics of etoposide (VP-16) after I.V. administration to children","volume":"11","author":"Eksborg","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clinthera.2015.05.495_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08880010252825722","article-title":"Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia","volume":"19","author":"Sauer","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib77","first-page":"243","article-title":"Severe renal toxicity due to intermediate-dose methotrexate","volume":"24","author":"Stark","year":"1989","journal-title":"Can Chemother Pharm"},{"key":"10.1016\/j.clinthera.2015.05.495_bib78","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MPG.0b013e3181d32756","article-title":"The influence of body mass index on outcome of pediatric chronic hepatitis C virus infection","volume":"51","author":"Delgado-Borrego","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clinthera.2015.05.495_bib79","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00467-008-1064-y","article-title":"Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease","volume":"24","author":"Hanafy","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib80","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1751-7176.2011.00502.x","article-title":"The efficacy and safety of valsartan in obese and non-obese pediatric hypertensive patients","volume":"13","author":"Meyers","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.clinthera.2015.05.495_bib81","doi-asserted-by":"crossref","unstructured":"Rose JB, Theroux MC, Katz MS. The potency of succinylcholine in obese adolescents. Anesth Analg 200;90:576-8.","DOI":"10.1097\/00000539-200003000-00015"},{"key":"10.1016\/j.clinthera.2015.05.495_bib82","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0310057X9001800409","article-title":"Suxamethonium\u2014electromyographic studies in children","volume":"18","author":"Brown","year":"1990","journal-title":"Anaesth Intens Care"},{"key":"10.1016\/j.clinthera.2015.05.495_bib83","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1081-1206(10)60791-0","article-title":"Improvement of asthma control with omalizumab in 2 obese pediatric asthma patients","volume":"97","author":"Kwong","year":"2006","journal-title":"Ann Allergy Immunol"},{"key":"10.1016\/j.clinthera.2015.05.495_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0264-410X(95)00176-2","article-title":"Hepatitis B immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination","volume":"14","author":"Minana","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2015.05.495_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08916930600597326","article-title":"Reduced tetanus antibody titers in overweight children","volume":"39","author":"Eliakim","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clinthera.2015.05.495_bib86","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/oby.2007.23","article-title":"Vitamin D status and response to vitamin D3 in obese vs. non-obese African American children","volume":"16","author":"Rajakumar","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.clinthera.2015.05.495_bib87","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ejcn.2011.5","article-title":"Higher vitamin D intake is needed to achieve serum 25(OH)D levels greater than 50 nmol\/L in Quebec youth at high risk of obesity","volume":"65","author":"Mark","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clinthera.2015.05.495_bib88","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000343446","article-title":"Response to vitamin D3 supplementation in obese and non-obese Caucasian adolescents","volume":"78","author":"Aguirre Castaneda","year":"2012","journal-title":"Horm Res Paediatr"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815008280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815008280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T03:40:52Z","timestamp":1599536452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815008280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0149291815008280"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.05.495","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}